Tessier-Lavigne Marc

Tessier-Lavigne Marc is listed in filings as Director at Denali Therapeutics Inc.. This profile follows SEC Form 4 activity through Jun 5, 2025, including 2 public disclosures. Recent filings connect the profile to Denali Therapeutics Inc. (DNLI). The current snapshot covers public activity from Jun 5, 2025. Reported amounts are shown as $252.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.